Matthew Snelson
Home
Publications
Presentations
Contact
CV
Page not found
Perhaps you were looking for one of these?
Latest
Example Page 1
Example Page 2
Targeting Methylglyoxal in Diabetic Kidney Disease Using the Mitochondria-Targeted Compound MitoGamide
Renal ACE2 (Angiotensin-Converting Enzyme 2) Expression Is Modulated by Dietary Fiber Intake, Gut Microbiota, and Their Metabolites
Processed foods drive intestinal barrier permeability and microvascular diseases
Long term high protein diet feeding alters the microbiome and increases intestinal permeability, systemic inflammation and kidney injury in mice
Gut microbiome, prebiotics, intestinal permeability and diabetes complications
Targeted deletion of NADPH-Oxidase Nox4 from proximal tubules is dispensable for diabetic kidney disease development
Microbial Peer Pressure: The Role of the Gut Microbiota in Hypertension and Its Complications
Deficiency of Prebiotic Fibre and Insufficient Signalling Through Gut Metabolite Sensing Receptors Leads to Cardiovascular Disease
Cite
×